BioSpace News Archive

Press Releases

ORYZON Announces First Patient Dosed in NCI-Sponsored Phase I/II Clinical Trial of Iadademstat Plus Immune Checkpoint Inhibitors in 1L Extensive Stage Small Cell Lung Cancer

April 15, 2025
·
7 min read
Press Releases

FluidForm Bio™ Advances Vascularized Tissue Engineering with New FRESH™ 3D Bioprinting Breakthrough

April 15, 2025
·
2 min read
Press Releases

Mural Oncology Announces Plans to Explore Strategic Alternatives

April 15, 2025
·
11 min read
Press Releases

Ensysce Biosciences Announces Positive Data from Opioid Overdose Protection Study

April 15, 2025
·
6 min read
Press Releases

eGenesis and OrganOx Announce U.S. FDA Clearance of IND Application for the Treatment of Patients with Acute-On-Chronic Liver Failure

April 15, 2025
·
4 min read
Press Releases

Oak Hill Bio Enters into Exclusive License Agreement with Roche to Obtain Global Rights for a Phase 3-Ready, Potential Best-in-Class Treatment for Individuals with Angelman Syndrome

April 15, 2025
·
4 min read
Press Releases

Hoth Therapeutics Announces Positive Initial Data in Phase 2a Clinical Trial

April 15, 2025
·
5 min read
Press Releases

Terumo Neuro Receives FDA Approval for Carotid Stent System

April 15, 2025
·
2 min read
Press Releases

Belhaven Biopharma Announces Positive Data From Their Nasdepi(R) Dose Confirmation Study in Patients With and Without Allergic Rhinitis

April 15, 2025
·
3 min read
Press Releases

Spruce Biosciences Announces New Corporate Strategy and Acquisition of Tralesinidase Alfa for the Treatment of Sanfilippo Syndrome Type B (MPS IIIB)

April 15, 2025
·
7 min read